The Patent Finder

Monte Rosa Therapeutics AG

Also on record
Records under this name other than the patents Monte Rosa Therapeutics AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.

Back to Monte Rosa Therapeutics AG

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
17/716,169Isoindolinone Compounds
Abandoned
Abandoned Feb 12, 2026
AbandonedAbandoned Feb 12, 2026
18/271,887Methods for the Identification of Degrons
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/271,954Treatment of Myc-Driven Cancers with GSPT1 Degraders
Abandoned
Abandoned Jul 14, 2026
AbandonedAbandoned Jul 14, 2026
18/471,563Pharmaceutical Compositions for Use in the Prevention and Treatment of a Disease or Disorder Caused by or Associated with One or More Premature Termination Codons
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/485,766Isoindolinone Compounds
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/485,780Isoindolinone Amide Compounds Useful to Treat Diseases Associated with GSPT1
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/565,163E3 Ligase Fusion Proteins for Proximity Detection
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/640,889Compounds That Mediate Protein Degradation and Uses Thereof
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/640,909Compounds That Mediate Protein Degradation and Methods of Use Thereof
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/640,987Compounds That Mediate Protein Degradation and Methods of Use Thereof
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
10 of 30 records shown.
Pro members see all 30.
Pro members: see all 30 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited